http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014202990-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a56e82e7ee8111cfcd7565412176b3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5440f4a5c76e85506140b85207148bb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_852a22da151deb6e747680ce8e5e90b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d3a315e9b27b70e139e9aa70e2b8f3
publicationDate 2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014202990-A1
titleOfInvention The use of phytocannabinoids in the treatment of ovarian carcinoma
abstract The present invention relates to the use of phytocannabinoids in the treatment of ovarian cancer. Preferably the phytocannabinoid is selected from the group consisting of: cannabidiol (CBD); cannabidiol acid (CBDA); cannabigerol (CBG); cannabigerolic acid (CBGA); cannabigerol propyl variant (CBGV); and tetrahydrocannabivarin (THCV). In a further embodiment the one or more phytocannabinoids are used in combination with each other. Preferably the combination of cannabinoids consists of CBD and CBG.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021144799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015198071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962341-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11440870-B2
priorityDate 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013038157-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008144475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2044935-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID327217186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5315659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323558827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID326173356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54226752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123356731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123751596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226595762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644019

Total number of triples: 51.